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ABSTRACT
Helicobacter suis colonizes the stomach of most pigs and is the most prevalent non-Helicobacter
pylori Helicobacter species found in the human stomach. In the human host, H. suis contributes to
the development of chronic gastritis, peptic ulcer disease and MALT lymphoma, whereas in pigs it is
associated with gastritis, decreased growth and ulcers. Here, we demonstrate that the level of H.
pylori and H. suis binding to human and pig gastric mucins varies between individuals with species
dependent speciﬁcity. The binding optimum of H. pylori is at neutral pH whereas that of H. suis has
an acidic pH optimum, and the mucins that H. pylori bind to are different than those that H. suis
bind to. Mass spectrometric analysis of mucin O-glycans from the porcine mucin showed that
individual variation in binding is reﬂected by a difference in glycosylation; of 109 oligosaccharide
structures identiﬁed, only 14 were present in all examined samples. H. suis binding to mucins
correlated with glycans containing sulfate, sialic acid and terminal galactose. Among the glycolipids
present in pig stomach, binding to lactotetraosylceramide (Galb3GlcNAcb3Galb4Glcb1Cer) was
identiﬁed, and adhesion to Galb3GlcNAcb3Galb4Glc at both acidic and neutral pH was conﬁrmed
using other glycoconjugates. Together with that H. suis bound to DNA (used as a proxy for acidic
charge), we conclude that H. suis has two binding modes: one to glycans terminating with
Galb3GlcNAc, and one to negatively charged structures. Identiﬁcation of the glycan structures H.
suis interacts with can contribute to development of therapeutic strategies alternative to antibiotics.
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Introduction
Helicobacter suis is a Gram negative, spiral shaped bacte-
rium which colonizes the stomach of 60–95% of pigs at
slaughter age and adult sows and boars [1–3]. H. suis col-
onization in the pig stomach is associated with chronic
gastritis, decreased daily weight gain [4] and ulcers in the
pars oesophagea (non-glandular stomach) [1,3]. H. suis is
the most prevalent non-Helicobacter pylori Helicobacter
species found in the human stomach, [5] signifying its
zoonotic importance. In the human host, H. suis has been
reported to contribute to the development of chronic gas-
tritis, [6] peptic ulcer disease [7] and gastric mucosa-asso-
ciated lymphoid tissue (MALT) lymphoma [8].
The ﬁrst barrier that gastric pathogens encounter is the
mucus layer, of which the main components are highly
glycosylated mucin glycoproteins [9]. In a healthy human
stomach, MUC5AC and MUC6 are the main secreted
mucins [10], however, in gastric disorders, expression of
MUC5B and MUC2 has also been described [11].
MUC5AC is a major constituent of the surface mucous
gel layer, whereas the expression of MUC6 is limited to
the glands [12]. In the pig stomach the mucins produced
by the surface epithelium differ from the gland mucins in
apoprotein content and length of the highly glycosylated
domains [13]. These mucins might represent the porcine
equivalents of the human MUC5AC and MUC6 mucins,
but their identity has not yet been deﬁned. Mucins carry a
multitude of branched oligosaccharide chains attached to
serine and threonine residues [14]. The high diversity of
mucosal oligosaccharide chains in the gastrointestinal
tract forms an extensive repertoire of potential binding
sites for bacteria [15–17].
Helicobacter pylori is the most common human gastric
pathogen, colonizing half of the world’s population [18].
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The majority of H. pylori reside in the gastric mucus layer
where they can bind to the gastric mucins [19]. The most
thoroughly investigated H. pylori adhesins are the blood
group antigen binding adhesin (BabA) that binds to Lewis
b (Leb) and H-type1 structures [20] and the sialic acid
binding adhesin (SabA) that binds N-acetyllactosamine-
based gangliosides with terminal a3-linked NeuAc, with a
preferential binding to sialyl-Lex (SLex) and sialyl-Lea
(SLea) [21,22]. Other outer membrane proteins (OMPs),
e.g. LabA, AlpA and AlpB, may also serve as adhesins
[23]. Across the gastric mucus layer, there is a pH gradient
ranging from acidic in the lumen to neutral at the epithe-
lial surface. Mucins from healthy humans carry mainly
neutral glycans, and bind to BabA positive H. pylori
strains in a Leb/H-type1 dependent manner and with a
neutral pH optimum [19,24]. Mucins from humans with
gastric inﬂammation or infection carry sialylated struc-
tures including SLea/x. Binding to these mucins occurs via
two mechanisms: via SabA with an apparent neutral pH
optimum, and via a charge dependent mechanism at
acidic pH [19,24]. H. suis genome analyses revealed that
H. suis lacks homologs of several H. pylori adhesion fac-
tors, including BabA, SabA, and the adherence-associated
lipoproteins AlpA and AlpB [25]. Conversely,H. suis con-
tains some OMPs similar to the major OMP families
described in H. pylori, which may be involved in binding
to the gastric mucosa, [25] such as HorB [26] and the H.
pylori adhesin A (HpaA) which was initially described as
a sialic acid binding adhesin, but later identiﬁed as a lipo-
protein [27].
The aims of the present study were to identify and fur-
ther characterize the pig gastric mucins, investigate if H.
suis binds to pig and human gastric mucins and glycolipids
and, if so, deﬁne binding-active structures. We demon-
strated that binding occurs to both human and pig mucins
and glycolipids. Furthermore, H. suis binding occurs via
twomodes of adhesion: to Galb3GlcNAcb3Galb4Glcb1 at
both neutral and acidic pH, and to negatively charged
structures at acidic pH.
Results
H. suis resides in the mucus layer above the
epithelial cells, but can also be found in the lamina
propria and associated with parietal cells
An antibody that recognizes isolated pig MUC5AC, [28]
stained foveolar epithelial cells as well as the thick
secreted mucus layer on pig gastric tissue sections
(Figure 1A), similarly to the distribution previously
shown for MUC5AC in the human stomach [29]. Fluo-
rescence in situ hybridization on gastric tissue sections
from H. suis infected pigs demonstrated the presence of
H. suis in the mucus layer lining the surface epithelium
Figure 1. Spatial distribution of MUC5AC and H. suis in porcine gastric specimens. A. Porcine gastric tissue ﬁxed with Carnoys ﬁxative to
retain the mucus layer was stained with a ﬂuorescently labelled antibody against MUC5AC (blue), demonstrating a thick mucus layer
above the epithelium. Nuclei and cytoplasm were stained with HCS CellMaskTM (red). B. Negative control for MUC5AC staining (i.e. no
MUC5AC antibody was added) with nuclei and cytoplasm outlined with HCS CellMaskTM (red). C, D, E. Fluorescent in situ hybridization
using an H. suis speciﬁc probe on H. suis –free (C) and infected (D, E) porcine gastric tissue sections. In these images, mucus is not visible,
but the tissue is outlined by dull green auto ﬂuorescence. H. suis (bright green color) was detected in the mucus layer in the gastric pits
(D). Of the H. suis present in the tissue, most were found in the lamina propria and/or associated with the (fried egg shaped) parietal
cells (E).
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and the gastric pits (Figure 1D), similarly to that H.
pylori resides in the mucus layer above the epithelial cells
[19,20]. In line with previously published electron micro-
graphs of H. suis inside canaliculi of the acid producing
parietal cell, [30,31] we also detected H. suis close to pari-
etal cells, although most of the H. suis in the tissue were
present in the intercellular space/lamina propria
(Figure 1E).
Characterization of mucins from pigs that were not
infected with H. suis
To identify the interaction between the porcine mucins
and the pathogen during the initial colonization, mucins
were isolated from the antral region of the gastric mucosa
of pigs determined to be free of gastric H. suis using PCR
and ﬂuorescent in situ hybridization. During the extrac-
tion of mucins from the tissue, surface mucus was sepa-
rated from the deeper gland material and mucins were
further divided into soluble and insoluble groups based
on their solubility in guanidinium chloride (GuHCl)
resulting in four sample groups for each pig (Figure 2A).
The mucins were puriﬁed from other proteins and DNA
using two subsequent isopycnic density gradient centrifu-
gation steps in 4 and 0.5 M GuHCl, due to that some
samples had some overlap between the mucin containing
fractions and the DNA containing fractions after the ﬁrst
centrifugation (Figure 2B and C). Mucins, localized by the
overlapping peaks of carbohydrate reactivity and antibody
reactivity against the MUC5AC mucin (Figure 2B and C),
were present as a peak with a maximum at the density
between 1.38 and 1.47 g/mL (1.41 § 0.005, mean § SEM,
Figure 2D). Distinct differences in density were neither
identiﬁed between mucins isolated from the surface epi-
thelium or glands, nor between soluble and insoluble
mucins, although the mucin density differed somewhat
between pigs. Quantiﬁcation of the carbohydrate content
under the mucin peaks showed that insoluble mucins
were slightly more predominant than soluble mucins in
all pigs; the proportion of insoluble mucins ranged from
Figure 2. Isolation, solubility and density of porcine gastric mucins. A. Each specimen was separated into four types of mucin samples
based on their tissue location and solubility in GuHCl. Mucins were then isolated from these samples using two steps of isopycnic CsCl
density-gradient centrifugation. B. Fractions from the ﬁrst density-gradient centrifugation (4 M GuHCl/1.39 g/mL) were analyzed for car-
bohydrate (~), MUC5AC (&), and DNA (─). The vertical dashed lines indicate how the mucin containing fractions were pooled for fur-
ther puriﬁcation in the second density-gradient centrifugation. C. Fractions from the second density-gradient centrifugation (0.5 M
GuHCl/1.50 g/mL) were analyzed for carbohydrate (~), MUC5AC (&), and DNA (─). The vertical dashed lines indicate how the mucin
containing fractions were pooled for further experiments. D. The density of the pig gastric mucins ranged from 1.38 to 1.47 g/mL. E.
The proportion of mucins that were insoluble in GuHCl, was higher than the soluble (Mann-Whitney U-test: p  0.05). Abbreviations:
SS: surface soluble, SI: surface insoluble, GS: gland soluble, GI: gland insoluble.
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52% to 71% (60.4 § 8.1, mean § SEM, Figure 2E). After
the second density gradient centrifugation, the mucin
containing fractions were again pooled to provide four
samples (surface soluble (SS), surface insoluble (SI), gland
soluble (GI) and gland insoluble (GI)) from each individ-
ual for further experiments.
Conﬁrmation of presence of MUC5AC in the porcine
stomach
In the healthy human stomach, MUC5AC, MUC6 and
MUC1 are expressed, and MUC2 and MUC5B can also
appear during disease [32]. Using antibodies against these
human mucins, we identiﬁed immunoreactivity against
MUC5AC in the porcine gastric surface epithelium
(Figure 1A) and against isolated porcine gastric mucins
(Figure 2B and C). In line with the histochemical results,
mass spectrometry analysis identiﬁed porcine MUC5AC in
six out of seven analyzed mucin samples (Supplementary
table 2). A total of 18 peptides were identiﬁed via LC-MS
[2] providing 16.8% coverage of the partially sequenced
porcine MUC5AC (entry pig_muc5acTSallignment http://
www.medkem.gu.se/mucinbiology/databases/index.html).
Porcine MUC6 (entry gi545805660) was also detected by
MS analysis but only in two out of seven samples analyzed
and only two matching peptides were found with 1.2%
protein sequence coverage. Porcine MUC5B (entry pig_-
muc5bTSallignmentAK238178.1_1_ORF1) was detected in
six out of seven samples with six peptides (coverage 7.5%).
Porcine MUC2 was not found in any of the samples, how-
ever, peptides homologous with human MUC2
(MJ080907, coverage 1.3%) was detected in one out of
seven samples, thus, we can not exclude the possibility
that small amounts of porcine MUC2 may be present.
The proteomic results support that MUC5AC is pres-
ent in pig stomachs, and indicate that MUC6 and
MUC5B also may contribute to the mucin repertoire of a
healthy porcine stomach.
H. suis binding to porcine mucins had an acidic pH
optimum and differed between individuals and
mucin types
We analyzed H. suis binding to gastric mucins isolated
from four pigs at pH 2–7, i.e. the pH range present in the
pig stomach. H. suis bound to mucins from all four pigs
at all pH tested (p  0.01). Binding was highest at pH 2
and gradually decreased towards neutral pH, though the
gradient differed between mucins, with some samples
retaining binding also at neutral pH whereas for other
samples binding was only detected at acidic pH
(Figure 3A). These results indicate that there may be two
types of interactions between H. suis and mucins: one
binding mode that is dependent on acidic pH and one
that is functional also at neutral pH.
H. suis and H. pylori binding to human gastric
mucins displayed opposite pH dependency and
differed in speciﬁcity
We selected pH 2, 4 and 7 to examine the binding of two
strains (H. suis HS1 and HS5) to 16 pig gastric mucin
samples puriﬁed from four H. suis negative pigs (P1-P4).
The H. suis mucin binding differed between individuals
(p  0.001, One-way ANOVA, Figure 4A-C), indicating
binding to a speciﬁc glycan structure/group of structures
via adhesin(s) as glycosylation differs between individu-
als. Furthermore, H. suis binding to GuHCl soluble
mucins was more pronounced than to insoluble ones
(p  0.01, Figure 3B) while no difference was detected
between mucins derived from gland or surface mucosa
(p = 0.798, Figure 3B).
Figure 3. Effect of pH and mucin type on H. suis binding to pig gastric mucins. A. pH dependence of H. suis binding to mucins. Results
are shown as mean § SEM of bacterial binding after subtraction of background signal at each pH.  and  indicate p  0.01 and
0.001, respectively, in an unpaired two sided t-test comparing the binding to the negative control background at each pH. This assay
was performed on four mucin samples, with similar results, ranging between the pronounced pH dependence shown with mucin 1 to
the ﬂatter curve seen with mucin 2. B. Effect of mucin type (surface (), gland (), soluble and insoluble) on H. suis binding at pH 2.
Results are expressed as medians with interquartile ranges.  indicates p  0.01 (Mann-Whitney U-test).
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Since H. suis is a zoonotic pathogen, we also investi-
gated binding to human mucins (H1-H5), selected
based on their previously described differences in
H. pylori binding ability and glycosylation [19,24,33].
Similarly to the binding pattern obtained with porcine
mucins, H. suis binding to human mucin samples dif-
fered between the ﬁve samples investigated, and the
most pronounced binding occurred at pH 2 and to sam-
ple H3 (Figure 4D-F). As the main difference between
the mucins is in glycosylation, this indicates that bind-
ing occurs to glycans. The binding speciﬁcity of H. suis
differed from that of H. pylori both with regards to that
H. pylori adhesion to mucins had a neutral pH opti-
mum, and that the mucins that H. pylori bound to came
from other individuals and were differently glycosylated
than the ones H. suis bound to (Pearson r: -0.05, com-
pare Figure 4D-F with Figure 4G-I). For H. pylori, the
differential binding pattern between the wild type J99
strain and its isogenic babA and sabA adhesin deletion
mutant, identiﬁed adhesin speciﬁc binding to human
samples 1, 4 and 5 at pH 5 and 7 (Figure 4G-I), and for
sample 4 and 5 some residual adhesin speciﬁc binding
remained also at pH 2. Binding with the H. pylori adhe-
sin deletion mutant at pH 2 was low and did not differ
between individual mucins (Figure 4G-I). Thus, that H.
suis binding differed between samples, together with
the results above, indicate that similarly to what previ-
ously has been described for H. pylori [19,24,34], H.
suis binding occurs to speciﬁc glycan structure(s) pres-
ent on mucins, although the structure speciﬁcity and
pH dependency differs from that of H. pylori.
To investigate if the binding pattern of the H. suis
strains HS1 and HS5 was representative for more H. suis
strains, we analyzed binding of another two strains (HSMf
and HSMm) to mucins that were chosen to display a
broad range of different glycans: a human mucin, a pig
mucin with high H. suis binding ability and a pig mucin
with low H. suis binding ability: all four strains had similar
binding speciﬁcities and pH preferences (Figure 5).
Porcine and human gastric mucin glycosylation
To elucidate the structures responsible for binding
and differences in binding between samples, we
Figure 4. H. suis binding to pig and human gastric mucins. A, B, C. H. suis strains HS1 and HS5 binding to pig mucin groups (SS – surface
soluble, SI – surface insoluble, GS – gland soluble, GI – gland insoluble) isolated from the stomach of four pigs (P1-4). D, E, F. Binding of
H. suis strains HS1 and HS5 to human gastric mucins isolated from ﬁve human patients (H1-H5). G, H, I. Binding of H. pylori strain J99
wild type and its isogenicDbabA/DsabA deletion mutant to human gastric mucins. Results are shown as mean§ SEM of bacterial bind-
ing after subtraction of background signal at each pH. ,  and  indicate p  0.05, 0.01 and 0.001, respectively, One Way ANOVA,
Dunnetts post hoc test.
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analyzed the carbohydrate structures present on the
mucins using mass spectrometry. Mass spectrometric
analysis of released mucin O-glycans was performed
on all four mucin fractions from three of the four
pigs: pig 3 was excluded from this analysis as histol-
ogy showed signs of inﬂammation even though no
infection was detected. We identiﬁed in total 109 oli-
gosaccharide structures in the examined porcine
mucin samples (43-93 structures from each sample
and 56–104 from each individual, supplementary
table 1). Only 14 of these were present in all of the
examined samples, which indicate high inter-individ-
ual variation among porcine gastric mucin glycan
structures. The oligosaccharides were mainly extended
core 1 (mean § SEM, 31.8 § 3.7%) and core 2 gly-
cans (mean § SEM, 66.5 § 4.0%) while the relative
abundances of extended core 3 and core 4 structures,
as well as the sialyl-Tn antigen (NeuAca2,6GalNAcol)
were below 1% (Figure 6A). The length of O-glycans
varied between 2 and 14 residues (Figure 6B), and
the glycans on GuHCl soluble mucins were shorter
than those on insoluble mucins. In addition, ﬁve
human mucin samples were selected for this study,
based on their high variation in mucin glycosylation,
thereby providing a wide range of potential structures
for bacterial binding [17]. We identiﬁed 176 O-linked
oligosaccharides (40-95 from each individual). The
characterized structures were mainly extended core 2
O-glycans (64 § 2%), although structures with core 1,
3 and 4 were also detected (Figure 6A). The relative
abundance of extended core 1 O-glycans was higher
in pig than human mucins (p < 0.001, Two-way
ANOVA). Only 14 of the 176 oligosaccharides were
present in all the ﬁve human samples. The glycan
chain lengths ranged from 2 to 12 residues
(Figure 6B). Since the terminal residues usually are
vital parts of the binding epitopes, we quantiﬁed the
relative abundance of these: galactose was the most
common terminal residue among pig glycans, whereas
fucose was most abundant among human mucins
(Figure 6C). Both human and pig mucins had a low
degree of sialylation (mean § SEM, pig: 4.3 § 1.1%,
human 16.0 § 6.8%). However, on 50% of the termi-
nal pig glycan structures a sulfate group was present
(mean § SEM, 50.25 § 5.1%), a modiﬁcation that
was virtually absent among the human samples (0.6
§ 0.2%, Figure 6C). The relative abundance of mucin
glycans with terminal galactose or sulfate were higher
in pigs than in humans (p < 0.001, p < 0.05, respec-
tively, Two-way ANOVA), whereas the relative abun-
dance of fucose terminating glycans were higher in
human mucins (p < 0.001, Two-way ANOVA).
Statistical correlations between H. suis binding
and mucin glycans
We analyzed the relation between the bacterial binding
amplitude and glycan structures: among the terminal
residues, the relative abundance of sulfated as well as
total acidic (i.e. sulfated and/or sialylated) glycans
detected correlated well with the level of H. suis binding
at pH 2 (Pearson r10 = 0.85, p  0.001, Figure 6D). The
maximum H. suis binding to any individual human
mucin was less than half compared to the binding to
porcine mucins. The human glycans carried low
amounts of sulfate (0 – 1%), however, the sample with
the most pronounced binding was the sample that had
the highest relative abundance of sialic acid (Figure 6D,
Table 1), indicating that one H. suis mucin binding
mode may be charge dependent. Of the 109 glycan
structures present on the porcine gastric mucin samples,
the abundance of seven glycans correlated with the H.
suis binding level at pH 2, whereof two were also asso-
ciated with binding at pH 7 (Table 2 and Figure 7).
The two structures the abundance of which was associ-
ated with binding at both neutral and acidic pH were
Galb4(S)GlcNAcb6(Fuca2Galb3)GalNAcol and GalNAc
a3(Fuca2)Galb3(SGlcNAcb6)GalNAcol (Figure 7). The
abundance of Galb4(S)GlcNAcb6(Fuca2Galb3)GalNA-
col glycan structure correlated the best with binding at
pH 2 (r = 0.94, p  0.001, structure identiﬁcation
shown in Figure 8).
Figure 5. Comparison of binding of four H. suis strains to pig and human gastric mucins. H. suis binding at pH 2 (A), pH 4 (B) and pH 7
(C) to a human mucin, a pig mucin with high H. suis binding ability and a pig mucin with low H. suis binding ability.
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H. suis binds to Galb3GlcNAcb3Galb4Glcb1Cer
glycolipid present in pig stomach
To identify the binding speciﬁcity of H. suis, we exam-
ined binding of 35S-labeled bacteria to glycosphingoli-
pids isolated from porcine stomach (Figure 9). Here, a
binding to a compound migrating in the tetraosylcera-
mide region was obtained (Figure 9B, lane 2). The H.
suis binding glycosphingolipid was also recognized by
H. pylori (Figure 9C, lane 2).
To further characterize the pig gastric glycosphingolipids,
the non-acid glycosphingolipid fractions from the four pigs
were hydrolyzed with Rhodococcus endoglycoceramidase II,
and the oligosaccharides obtained were analyzed by LC-ESI/
MS using a graphitized carbon column [35]. LC-ESI/MS of
oligosaccharides, using graphitized carbon columns, gives
Figure 6. Porcine and human mucin O-glycosylation. A. Relative abundance of pig and human structures containing core 1–4 and sialyl-
Tn. B. Size distribution (number of carbohydrate residues/glycan) of pig and human mucin O-glycans. C. Relative abundance of terminal
glycan residues and sulfation on pig (n = 3, 12 subfractions) and human (n = 5) mucin glycans. Stars indicate statistically signiﬁcant dif-
ference between pig and human mucin glycans, ,  and  indicate p  0.05, 0.01 and 0.001, respectively, Two-way ANOVA. D. Scatter
plot of the amplitude of H. suis binding to mucins at pH 2 against their relative abundance of acidic glycan structures among pig (mainly
sulfated structures, black) and human (mainly sialylated structures, grey). The r in the ﬁgures denotes the Pearson correlation coefﬁcient,
pooled for the human and pig data (pig mucins only: r = 0.85, human samples alone are too few to perform correlation analysis on).
Table 1. Relative abundance of human mucin glycan structures that correlated with H. suis binding in pig mucins (Table 2). Abundance
of human mucin glycan motifs implicated to potentially be of relevance to H. suis binding from the statistical correlations between bind-
ing and relative abundance on pig mucins (Table 2). Although the number of samples was too low to perform correlation studies, sialy-
lated and sulfated structures terminating in Gal and overall sialylated and sulfated structures were highest in sample H3, coinciding
with that this sample had the highest H. suis binding ability (Figure 4).
Relative abundance (%)
Carbohydrate epitope H1 H2 H3 H4 H5
Acidic structures (sialylated and/or sulfated) 10 10 40 24 0
Gal terminating structures (including blood group B) 8 72 30 49 60
Gal terminating acidic structures 2 4 12 9 0
GalNAc terminating structure (blood group A and LacdiNAc) 1 4 1 19 21
Fuca2Galb3 (ABH blood group antigens) 60 7 33 28 27
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resolution of isomeric saccharides, and the carbohydrate
sequence can be deduced from series of C-type fragment
ions obtained by MS2. In addition, diagnostic cross-ring
0,2A-type fragment ions are present in MS2 spectra of oligo-
saccharides with a Hex or HexNAc substituted at C-4, and
thus allow differentiation of linkage positions.
The base peak chromatogram obtained from LC-ESI/MS
of the oligosaccharides obtained by hydrolysis of theH. suis
binding non-acid fraction from pig 2 (shown in Figure 9A
and B, lane 2) is shown in Figure 9D. Molecular ions corre-
sponding to oligosaccharides ranging from trisaccharides
(detected as [M-H+]¡ ions at m/z 503) to heptasaccharides
Table 2. Porcine mucin glycan structures whose relative abundance correlate with the amplitude of H. suis binding to the mucins at pH
2 (A) or pH 7 (B). The two structures that had statistical correlation (p < 0.05) at both pH 2 and pH 7 are indicated with . There were
no positive statistical associations with the remainder of the identiﬁed glycan structures (listed in supplementary table S1).
Correlation with binding
Mass (m/z) Structure p value Pearson r Relative abundance (%)
A
667 6SGlcNAcb1,6(Galb3)GalNAcol p  0.01 0.7371 2 – 7
813 SGlcNAcb6(Fuca2Galb3)GalNAcol p  0.05 0.6963 2 – 17
870 GlcNAca4(S)Galb3(GlcNAcb6)GalNAcol p  0.01 0.7111 0 – 5
975 Galb4(S)GlcNAcb6(Fuca2Galb3)GalNAcol p  0.001 0.9357 0 – 2
1016 GalNAca3(Fuca2)Galb3(SGlcNAcb6)GalNAcol p  0.01 0.7952 0 – 6
1121 Fuca2Galb4(S)GlcNAcb6(Fuca2Galb3)GalNAcol p  0.01 0.749 0 – 6
1381 GalNAca3(Fuca2)GalGlcNAcb3Galb3(SGlcNAcb6)GalNAcol p  0.05 0.6778 0 – 1
B
733 GalNAca3(Fuca2)Galb3GalNAcol p  0.01 0.7849 0 – 2
975 Galb4(S)GlcNAcb6(Fuca2Galb3)GalNAcol p  0.05 0.712 0 – 2
1016 GalNAca3(Fuca2)Galb3(SGlcNAcb6)GalNAcol p  0.01 0.7788 0 – 6
Figure 7. Scatter plots between H. suis adhesion and the relative abundance of the two structures that were associated with binding at
both pH 2 and 7. The r in the ﬁgures denotes the Pearson correlation coefﬁcient.
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Figure 8. Identiﬁcation of the m/z 975.25 structure (Galb4(6S)GlcNAcb6(Fuca2Galb3)GalNAcol) from porcine gastric mucin O-glycans by
LC-MS/MS. A. Extracted ion chromatogram (EIC) of m/z 975.25 [M-H]¡ B. Collision-induced dissociation (CID)-based MS/MS fragmenta-
tion spectra with annotated fragments C. Higher-energy collisional dissociation (HCD)-based MS/MS low mass region (m/z 110–390)
showing fragments speciﬁc for blood group H on C3 arm and a type 2 LacNAc on C6 with 6-linked sulfate on GlcNAc.  denotes back-
ground ions. The Consortium for Functional Glycomics cartoons were used to represent O-linked glycan structures.
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Figure 9. Characterization of H. suis binding glycosphingolipids from pig stomach. A. Thin-layer chromatogram after detection with anisalde-
hyde B. Autoradiogram obtained by binding of 35S-labeled H. suis (HS5) at pH 7.2. C. Autoradiogram obtained by binding of 35S-labeled H. pylori
strain J99 wt at pH 7.2. The glycosphingolipids were separated on aluminum-backed silica gel plates, using chloroform/methanol/water 60:35:8
(by volume) as solvent system. Lanes 1–4 were total non-acid glycosphingolipids isolated from the stomach of four individual pigs, 40mg/lane.
D-G. LC-ESI/MS of the oligosaccharides obtained by digestion of the non-acid glycosphingolipid fraction of pig stomach (shown in chart A, lane
2) with Rhodococcus endoglycoceramidase II. D. Base peak chromatogram from LC-ESI/MS of the oligosaccharides derived from the non-acid gly-
cosphingolipid fraction of pig stomach. E. MS2 spectrum of the ion atm/z 706 (retention time 14.2 min). F. MS2 spectrum of the ion atm/z 706
(retention time 18.3 min). G. MS2 spectrum of the ion atm/z 706 (retention time 18.5 min). H. Interpretation formulas showing the deduced oli-
gosaccharide structures. Gb3, Gala4Galb4Glc; Gb4, GalNAcb3Gala4Galb4Glc; A6-1, GalNAca3(Fuca2)Galb3GlcNAcb3Galb4Glc; Ley-6,
Fuca2Galb4(Fuca3)GlcNAcb3Galb4Glc; H5-1, Fuca2Galb3GlcNAcb3Galb4Glc; L4, Galb3GlcNAcb3Galb4Glc; nL4, Galb4GlcNAcb3Galb4Glc; H5-
2, Fuca2Galb4GlcNAcb3Galb4Glc; Gala3-nLc4, Gala3Galb4GlcNAcb3Galb4Glc; x2, GalNAcb3Galb4GlcNAcb3Galb4Glc; Gala3-nLc4,
Gala3Galb4GlcNAcb3Galb4GlcNAcb3Galb4Glc; GbA, GalNAca3(Fuca2Galb3GalNAcb3Gala4Galb4Glc.
VIRULENCE 907
(were detected as [M-H+]¡ ions atm/z 1217 and 1233) were
found. All molecular ions were subjected to MS2, and the
oligosaccharides thereby identiﬁed are given in the legend of
Figure 9. Molecular ions atm/z 706 correspond to an oligo-
saccharide with one HexNAc and three Hex. Here, three
sets of peaks at m/z 706 were present, eluting at 14.2 min,
18.3 min and 18.5 min, respectively. The MS2 spectrum of
the ion at m/z 706 at retention time 14.2 min (Figure 9E)
had a C-type fragment ion series (C1 at m/z 220, C2 at m/z
382, and C3 at m/z 544), demonstrating a HexNAc-Hex-
Hex-Hex sequence. The 0,2A3 fragment ion atm/z 484 dem-
onstrated a 4-substituted Hex. Thus, a globotetra saccharide
(GalNAcb3Gala4Galb4Glc) was tentatively identiﬁed. MS2
of the ion at m/z 706 at the retention time 18.7 min
(Figure 9F) allowed a preliminary identiﬁcation of a lactote-
tra saccharide (Galb3GlcNAcb3Galb4Glc). This was con-
cluded from the C-type fragment ions (C2 at m/z 382 and
C3 at m/z 544) identifying a Hex-HexNAc-Hex-Hex
sequence. This MS2 spectrum had a prominent D1-2 ion at
m/z 202, which is obtained by a C2-Z2 double cleavage and
diagnostic for a 3-substituted HexNAc [36]. The MS2 spec-
trum also lacked a 0,2A2 fragment ion at m/z 281, further
demonstrating that the HexNAc was substituted at 3-posi-
tion. Thus, LC-ESI/MS veriﬁed the presence of lactotetrao-
sylceramide in the H. suis binding glycosphingolipid
fraction. The MS2 spectrum of the ion at m/z 706 at the
retention time 18.5 min (Figure 9G) was different. This
spectrum had a prominent 0,2A2 fragment ion at m/z 281,
and a 0,2A2-H2O fragment ion- atm/z 263, demonstrating a
terminal Hex-HexNAc sequence with a 4-substitution of
the HexNAc, i.e. a type 2 chain. In combination with the C2
ion atm/z 382 and the C3 ion atm/z 544, this demonstrated
a neolactotetra saccharide (Galb4GlcNAcb3Galb4Glc). The
three MS2 spectra all had 0,2A4 ions at m/z 646, and
0,2A4-
H2O ions at m/z 628, which were derived from cross-ring
cleavage of the 4-substituted Glc of the lactose unit at the
reducing end.
In subsequent binding assays using pure and structurally
characterized reference glycosphingolipids a binding of
H. suis to lactotetraosylceramide (Galb3GlcNAcb3Gal
b4Glcb1Cer) was observed, whereas lactotriaosylceramide
(GlcNAcb3Galb4Glcb1Cer), neolactohexaosylceramide
(Galb4GlcNAcb3Galb4GlcNAcb3Galb4Glcb1Cer) and
globotetraosylceramide (GalNAcb3Gala4Galb4Glcb1Cer)
were non-binding (data not shown). There was no binding
of H. suis to the acid glycosphingolipids (sulfatide and gan-
gliosides) of porcine stomach (data not shown). It should
here be noted that due to too low incorporation of radioac-
tive label into the fastidiousH. suis, the results from the gly-
cosphingolipid binding assays were difﬁcult to reproduce,
and in many cases no signal was obtained. Therefore we
next investigated ifH. suis bound to Lacto-N-tetraose (LNT,
Galb3GlcNAcb3Galb4Glc) conjugated to human serum
albumin (HSA) using the same microtiter based assay that
we used for themucin binding analysis.
H. suis binds to a synthetic Galb3GlcNAcb3Galb4Glc
conjugate at both acidic and neutral pH and at
acidic pH to DNA (proxy for acidic charge)
In line with the glycolipid binding results, H. suis
bound to LNT conjugated to HSA at pH 7 (p  0.05,
Figure 10A) and in line with that H. suis did not
bind to neolactohexaosylceramide (Galb4GlcNAcb3
Galb4GlcNAcb3Galb4Glcb1Cer), no binding was
detected to HSA conjugated Lacto-N-neotetraose
(LNnT, Galb4GlcNAcb3Galb4Glc). No binding was
detected to the H. pylori binding structures Leb and
SLex conjugated to the same carrier either
(Figure 10A). The H. suis LNT binding ability
remained functional at pH 2 (Figure 10B). Since Gal
was present in the vicinity of acidic structures in the
glycans that were highly associated with binding at
pH 2 among the mucin glycans, and there was also a
correlation with overall acidic glycans, we hypothe-
sized acidic charge may also confer binding and/or
that acidic modiﬁcation on Galb3GlcNAc may have
beneﬁcial effects on binding. To investigate the ﬁrst
option, we analyzed binding to DNA, which carries a
high density of negative charge. H. suis did indeed
bind DNA at pH 2, demonstrating that negative
charge per se also confer binding at pH 2
(Figure 10B), but not at pH 7 (Figure 10A).
H. suis binding to mucins can be inhibited by
synthetic Galb3GlcNAcb3Galb4Glc and
Neu5Aca2,3Galb3GlcNAcb3Galb4Glc
Finally, we demonstrated that binding to pig mucins
could be inhibited by pre-treating the bacteria with
LNT or sialylated LNT (LS-tetrasaccharide a (LSTa),
Neu5Aca2,3Galb3GlcNAcb3Galb4Glc) (p  0.01,
One-way ANOVA, Dunnetts post hoc test)
(Figure 10C) Similar to the porcine glycolipids, we
identiﬁed the presence of type 1 chains in the porcine
mucin, where a low molecular structure Galb3Glc-
NAcb3Galb3GalNAc was identiﬁed with a relative
abundance of 0–5.5%, while type 2 chains appeared
to be the dominant lactosamine units.
Discussion
We found H. suis in the porcine gastric mucus layer cov-
ering the epithelial cells, in lamina propria and in associ-
ation with acid producing parietal cells. This suggests
that the pathogen is exposed to neutral pH when it is
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present in the lamina propria and mucus close to the epi-
thelial cells and to acidic pH further out towards the gas-
tric lumen as well as when inside parietal cell canaliculi.
We characterized the gastric mucins and the mucin gly-
cosylation from H. suis-free pigs, with regards to mucin
species, solubility and glycosylation, i.e. the environment
that H. suis meets upon entry to the porcine stomach.
We also identiﬁed glycolipids present in the porcine
stomach, which may confer more intimate H. suis adher-
ence than mucins. H. suis bound to both mucins and gly-
colipids. H. suis binding to porcine mucins had an acidic
pH optimum, differed between individuals and mucin
types, and consisted of two binding modes: one that is
active only at acidic pH and one that is active at both
acidic and neutral pH. H. suis bound Galb3Glc-
NAcb3Galb4Glc on glycoconjugates at both neutral and
acidic pH, and to negatively charged structures at acidic
pH (visualized in Figure 11), and binding to mucins can
be inhibited by Galb3GlcNAcb3Galb4Glc both with and
without terminal sialylation.
In line with studies showing that H. suis can be pres-
ent inside canaliculi of the parietal cell [30,31], we found
H. suis in lamina propria and in association with acid
producing parietal cells. The mechanism used by H. suis
to enter the tissue is currently unknown. The tightly
coiled spiral shape and high number of ﬂagella on H.
suis cells [37] together with the urease activity (that can
be directly associated with motility [38) might contribute
to the migration of this pathogen into the intracellular
canaliculi of gastric parietal cells.
Porcine gastric mucins have previously been demon-
strated to be large, oligomeric and highly glycosylated,
similarly to human mucins [39,40]. Porcine gastric
mucins can be commercially obtained in bulk, however,
due to the high prevalence of H. suis infection in pigs
(60-95%), [1–3] both previous studies and the commer-
cially available mucins are most likely from infected pigs.
Here, we characterized the glycosylation of gastric
mucins isolated from H. suis-free pigs. Out of the tree
pigs, two were 8 weeks old and one was 4 months old at
the time of euthanization. Age-related glycosylation dif-
ferences that have been reported between 21d and 180d
old pigs [41] were not observed in our samples, and the
mucin glycan proﬁle differed to a similar degree between
the 8 week old pigs as between the 8 week and 4 months
old pigs, suggesting that the detected differences were
genetic rather than age-related. Among three studied
pigs, we found 109 oligosaccharide structures, whereof
only 14 were present in all the examined samples. This
indicates high inter-individual variation among porcine
gastric mucin glycans, similar to what we previously
have shown for human gastric mucins [17]. The higher
number of structures found among the human mucin
glycans cannot be taken as evidence of higher inter-indi-
vidual variability in humans than in pigs, as the human
samples also include pathological specimens. A major
difference between porcine and human gastric mucin
glycans is that sulfation, a modiﬁcation virtually absent
among human mucin glycans from healthy stomachs, is
a common feature on porcine glycans.
Here we used four methods to analyzeH. suis binding
to glycan structures: Binding of 35S-labeled bacteria to
glycosphingolipids on thin-layer chromatograms,
microtitre based assays using anti-Helicobacter antibody
detection or biotinylated bacteria as detection system
and binding inhibition assays. Overall, binding was
Figure 10. H. suis binding to synthetic glycoconjugates and inhibition of H. suis mucin binding. A. H. suis (HS1) binding to pig gastric
mucin, LNT, LNnT, Leb, Slex (glycans conjugated to HSA) and DNA at pH 7. B. H. suis binding to pig gastric mucin, LNT conjugated to
HSA and DNA (used as a marker for acidic charge without structural resemblance of mucins) at pH 2. C. Binding of H. suis to mucins was
inhibited by pre-treatment of the bacteria with LNT and LSTa. To conﬁrm the speciﬁcity of the inhibition, the experiment was also per-
formed with monosaccharides that are part of the structures that inhibited binding (glucose, galactose, N-acetyl-glucosamine) and also
with unrelated monosaccharides (fucose, N-acetyl-galactosamine). None of these structures interfered with the binding of the bacteria
to the mucin (data not shown). Data are shown after subtracting background control for each pH.  indicates p  0.05,  p  0.01 and
 p  0.001, One-way ANOVA, Dunnetts post hoc test.
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relatively weak compared to the level of adhesion found
with H. pylori. We did have occasional negative binding
results, possibly due to the weak character of the bind-
ing, low level of incorporation of radioactive label, or
phase variation. The results (both positive and negative
binding) shown in this manuscript are only those that
were reproduced with at least two methods. We occa-
sionally also detected weak adhesion to other structures
(data not shown). These data indicate that H. suis also
may bind to other structures under certain circumstan-
ces. Some of the binding modes found were present at
acidic pH, raising a potential concern that the binding
may be due to protein denaturing and becoming gener-
ally ‘sticky’. However, the binding data is presented after
subtracting the background signals of the assay at each
pH. Furthermore, the effect of pH on bacterial binding
to mucins varied between the mucin samples tested.
Among the mucins, there were both human and pig
mucins that did not bind H. suis (e.g. H2 and P4 SI) at
pH 2 and others that displayed strong binding (e.g. H3
and P2 SS). If the binding signal was due to adhesion to
denatured protein, the increased signal would be
expected to occur to all samples, as the amount of pro-
tein core with potential to become denatured is similar
between samples. In addition, binding was inhibited by
addition of glycan structures, and binding at acidic pH
also occurred to DNA, suggesting that binding at acidic
pH occurs to charged structures, not to denatured pro-
teins. Both gastric mucins and H. suis are adapted to the
acidic environment of the stomach, and this may be a
reason that protein denaturation did not cause problems
in our assays. H. pylori, a close relative of H. suis, binds
to gastric mucins via several modes of adhesion, whereof
the BabA and SabA adhesins binding to Leb and SLex
blood group antigens in the mucins have been particu-
larly well characterized [40,42–44]. The BabA and SabA
adhesins are absent in the genome of H. suis. The por-
cine and human mucin glycans carry a large range of
complex structures, but mucins can carry similar glyco-
epitopes as glycolipids, and act as a decoy for the inti-
mate adherence conferred by Helicobacter adhesion to
glycolipids in the gastric epithelium [21,43,45]. In addi-
tion to being the most likely host target that would be
beneﬁcial for the pathogen to adhere to, the use of glyco-
lipids simpliﬁes the investigation of the binding speciﬁc-
ity, since these compounds have only one glycan, in
contrast to the multiple glycans carried by mucins. 35S-
labeled H. suis bound to Galb3GlcNAcb3Gal
b4Glcb1Cer. Although low incorporation of radioactive
label into this fastidious pathogen made the results difﬁ-
cult to reproduce, we also demonstrated binding to
Galb3GlcNAcb3Galb4Glc at both acidic and neutral pH
using methods independent of metabolic labelling. In
line with the present observation that H. suis bound lac-
totetraosylceramide in pig stomach, H. pylori binding to
lactotetraosylceramide has been identiﬁed in human
gastric epithelium, [46] and may thus also function as a
H. suis human gastric epithelial cell attachment factor.
Sulfated lactotetraosylceramide has not been character-
ized, whereas sialyl-lactotetraosylceramide has to date
Figure 11. Schematic representation of the two binding modes of H. suis. H. suis binds to Galb3GlcNAcb3Galb4Glcb1 at both neutral
and acidic pH and to negatively charged glycan structures at acidic pH. Galb3GlcNAcb3Galb4Glcb1 is present both on glycolipids at the
epithelial surface where pH is close to neutral and on secreted mucins in the mucus layer where pH range from neutral to acidic, and H.
suis binding can thus occur to this structure both when present on glycolipids and on mucins. H. suis binding to negatively charged gly-
can structures at acidic pH is likely to mainly occur to mucin glycans and shed DNA at a distance from the epithelial surface where the
pH is acidic. Potentially binding to these structures could also occur after tissue invasion, i.e. at neutral pH when H. suis is present in the
lamina propria and at acidic pH inside parietal cell canaliculi, however, the distribution of these structures in lamina propria and parietal
cells is unknown.
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only been found as an early fetal ganglioside in the
brains of young children, [47] and in human meconium
[48] and it is not recognized byH. pylori [22, 46].
In pigs and humans, structures binding H. suis are
present both on mucins and glycolipids. Different opin-
ions on the outcome of mucin binding to pathogens exist,
where some scientists appear to be of the opinion that
binding to mucins gives H. pylori a reservoir for re-infec-
tion, although we have not seen any experimental data
supporting this. We have, however, several lines of sup-
port for the function of mucins as decoys for the more
intimate adherence to glycolipids. Both in the rhesus
monkey model of H. pylori infection and in a study of
pediatric patients, individuals with mucins with high H.
pylori binding ability had a lower amount of H. pylori in
their stomach and lower gastritis than individuals with
low binding ability [29,43]. Furthermore, the membrane
bound mucin MUC1 can act as a releasable decoy hinder-
ing prolonged adherence to epithelial cells in vitro, and
mice lacking this mucin develop more severe gastritis [45].
The statistical correlation analysis betweenH. suis adhe-
sion to mucins and amount of speciﬁc glycan structures
implicated two structures to be relevant for binding at neu-
tral pH: Galb4(S)GlcNAcb6(Fuca2Galb3)GalNAcol and
GalNAca3(Fuca2)Galb3(SGlcNAcb6)GalNAcol. How-
ever, we detected no binding to LNnT (Galb4Glc-
NAcb3Galb4Glc) conjugated to HSA nor to Galb4
GlcNAcb3Galb4GlcNAcb3Galb4Glcb1Cer or GalNAca3
(Fuca2)Galb3GlcNAcb3Galb4Glcb1Cer, which migrates
at a lower level than where we detected H. suis binding on
the thin layer chromatography. Thus, either other parts of
the molecules than these are important for the adhesion or
these correlations are not casually related. However, at
acidic pH, correlation analysis implicated that sialylation
and sulfation were important, a notion that we then dem-
onstrated to be functional both by showing binding to
DNA (as a proxy for structurally unrelated negative
charge) and by partially inhibiting binding tomucins using
a sialylated glycan.
In conclusion, we demonstrated that H. suis binding
occurs via two modes of adhesion: to Galb3GlcNAc
b3Galb4Glcb1 at both neutral and acidic pH, and to
negatively charged structures at acidic pH. Further-
more, binding occurs to both mucins and glycolipids.
Since binding glycolipids confer close adherence to
host epithelial cells, whereas mucins can act as decoys
and hinder access to the epithelial cell surface, the bal-
ance between adhesion to mucins versus glycolipids is
probably important for the colonization process and
the outcome of the disease. Knowledge on the struc-
tural basis for these host-pathogen interactions may
contribute towards the development of breeding or
treatment strategies to prevent diseases.
Materials and methods
Samples
Porcine samples
The Helicobacter infection status of surface and gland
mucosa samples collected from the antrum of the stom-
ach from 8 weeks, 4 months and 6 months old pigs origi-
nating from different Belgian pig herds (Rattlerow
Seghers sow x Pietrain boar), was determined by ﬂuores-
cence in situ hybridization (FISH, described below) and
PCR. DNA was extracted with the DNeasy Tissue Kit
(Qiagen, Hilden, Germany) and PCR for H. suis was per-
formed as described by De Groote and colleagues. [2]
Four pigs were deemed free of H. suis infection, and
examination of hematoxylin and eosin stained sections
from the antrum further conﬁrmed that the H. suis nega-
tive specimens had a normal histological appearance.
Mucins were isolated from these 4 pigs not infected with
H. suis (pig 1 and pig 2 were 8 weeks old, pig 3 was
6 months old and pig 4 was 4 months old). Samples
from these pigs, as well as from pigs naturally infected
with H. suis (collected from slaughterhouses) were used
for histology.
Human samples
Five samples were selected for this study, based on that
they varied highly in mucin glycosylation, [17] thereby
providing a wide range of structures for potential differen-
tial binding to bacteria. Two samples were from gastric
adenocarcinoma tumor (intestinal type) and two were
from macroscopically normal mucosa of tumor-affected
stomachs, as evaluated by a clinical pathologist. Addition-
ally, one specimen was from the whole gastric wall of a
patient who underwent elective surgery for morbid obesity.
This patient had no history of peptic ulcer disease, and the
stomach was macroscopically normal at the time of opera-
tion. The samples with normal histology were obtained
after informed consent and approval of the local ethical
committee (Lund University Hospital, Lund, Sweden),
whereas the mucins from the tumor samples was from our
well characterized mucin library, and these sample were
collected in 1983 at the IMIM-Hospital del Mar, Barce-
lona, Spain (before the hospital had an ethics committee).
Immunoﬂourescence
5 mm thick tissue sections were cut from porcine gastric
tissue specimens ﬁxed in Carnoy’s solution and embed-
ded in parafﬁn. Sections were deparafﬁnized and rehy-
drated in sequential washes of 95%, 80% and 50% ethyl
alcohol, and antigen retrieval was performed using
10 mM sodium citrate (pH 6.0) at 95C for 10 min. Non-
speciﬁc binding was blocked with 1% BSA for 1h.
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Primary antibody anti-MUC5AC (45M1; Sigma-Aldrich,
M5293) was diluted 1:1,000 and incubated at 4C for
3 h. Sections were washed with cold PBS (140 mM NaCl,
2.7 mM KCl, 10 mM phosphate buffer, pH 7.4) 3 times
and incubated with anti-mouse secondary antibody con-
jugated with Alexa Fluor 350 (Life Technologies,
A11045), diluted 1:200 at 4C for 3 h. Sections were
incubated with HCS CellMaskTM Red Stain (Thermo-
Fisher, H32712) diluted 1:14,000 at RT for 30 min. Sec-
tions were washed again with cold PBS 2 times and with
water one time and mounted with ProLong® Gold Anti-
fade Mountant (Life Technologies, P36934).
FISH
Five mm pig gastric tissue sections from the pigs that
mucin samples were isolated from and 7 pigs naturally
infected with H. suis and ﬁxed in Carnoy’s solution were
deparafﬁnized and rehydrated in sequential washes of
95%, 80% and 50% ethyl alcohol. After air drying, a
hybridization cocktail containing 40% formamide, 0.1%
SDS, 0.9M NaCl, 20mM Tris pH 7.4, nuclease free water
and 10 ng/mL ﬂuorescently labeled probes (EUB338
probe: 5 0-GCTGCCTCCCGTAGGAGT-3 0 and H. suis
speciﬁc probe: 5 0-TCTCAGGCCGGATACCCGTCA-
TAGCCT-3 0) were added to the sections, and they were
placed in a humidiﬁed chamber and incubated at 37C
overnight. The slides were washed in wash buffer con-
taining 0.9M NaCl, 25mM Tris pH 7.4 at 50C for
20 min. They were dipped in room temperature distilled
water very brieﬂy, dried at room temperature and
mounted with ProLong® Gold Antifade Mountant con-
taining DAPI (Life technologies, P36935).
Isolation of gastric mucins
From pigs
Mucins were isolated from the antrum of 4 pigs without
H. suis infection. Tissues were stored at -80C after exci-
sion. The frozen tissue pieces were drenched in 10 mM
sodium phosphate buffer (pH 6.5) containing 0.1 mM
phenylmethyl sulphonyl ﬂuorid (PMSF). The surface
and gland mucosa of the antrum of the pig stomachs was
removed by scraping the tissue with a glass microscope
slide. The scrapings were placed into ﬁve volumes of
extraction buffer (6 M GuHCl, 5 mM EDTA, 10 mM
sodium phosphate buffer, pH 6.5) containing 0.1 M
PMSF and were dispersed with a Dounce homogenizer
(four strokes with a loose pestle) and stirred slowly at
4C overnight. The insoluble material was removed by
centrifugation at 23,000 £ g for 50 min at 4C (Beckman
JA-30 rotor). The supernatant corresponded to the
GuHCl soluble mucins and the pellet was re-extracted
twice with 10 mL extraction buffer. The ﬁnal extraction
residue was reduced with 10 mL of 10 mM 1,4-dithio-
threitol (DTT) in reduction buffer (6 M GuHCl, 5 mM
EDTA, 0.1 M Tris-HCl buffer, pH 8.0) for 5 h at 37C
followed by alkylation with 25mM iodoacetamide over-
night in the dark at 23–24C. After centrifugation at
23,000 £ g for 50 min at 4C (Beckman JA-30 rotor),
the supernatant contained the GuHCl insoluble mucins.
The insoluble and soluble samples were dialyzed against
10 volumes of extraction buffer for 8 h and 24 h, respec-
tively. The samples were adjusted to 26 mL with extrac-
tion buffer. CsCl was added to the samples to give
1.39 g/mL starting density by gentle stirring. The samples
were transferred into Quick Seal ultracentrifuge tubes
and centrifuged at 40,000 £ g for 90h at 15C. The frac-
tions were collected from the bottom of the tubes with a
fraction collector equipped with a drop counter. After
this procedure, the mucins were largely separated from
the non-mucin low glycosylated proteins (as determined
in combination with the carbohydrate detection method
below), however, in some samples there was a partial
overlap between the DNA peak and the mucins, and
thus, all mucins were further puriﬁed by pooling and
diluting the mucin containing fractions in CsCl/0.5 M
GuHCl and repeating the ultracentrifugation, as
described above, with a starting density at 1.50 g/mL.
Again, the fractions were analyzed for density using a
Carlsberg pipette as a pycnometer and for DNA content
by measuring absorbance at 260 nm for carbohydrate
content (below) and for MUC5AC using enzyme-linked
immunosorbent assay (ELISA) (below).
From humans
Rinsed and frozen tissue pieces were drenched in 10 mM
sodium phosphate buffer (pH 6.5) containing 0.1 mM
PMSF. The surface and sub-mucosa of normal tissue was
removed by scraping the tissue with a glass microscope
slide. Tumor tissue was homogenized without prior
scraping. The material was immersed in liquid nitrogen
and pulverized in a Retch tissue pulverizor (Retch GmBH
& Co., Haan, Germany), then placed into ﬁve volumes of
extraction buffer containing 0.1 mM PMSF and dispersed
using a Dounce homogenizer (four strokes with a loose
pestle) and stirred slowly at 4C overnight. The insoluble
material was removed by centrifugation at 23,000 £ g for
50 min at 4C (Beckman JA-30 rotor). In this study, we
only used mucins present in the supernatant, where most
of the human MUC5AC and MUC6 molecules usually
are found. Supernatants were dialyzed against ten vol-
umes of extraction buffer for 24 h and then ﬁlled up to
26 mL with extraction buffer. Cesium chloride was added
to the samples to give 1.39 g/mL starting density by gentle
stirring. The samples were centrifuged at 40,000 £ g for
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90 h at 15C. Analytical assays on mucin fractions were
performed as for the pig mucins.
Carbohydrate detection
Gradient fractions were diluted in 0.5 M GuHCl and
coated on to Nunc 96-well polisorp plates (Thermo-
Fisher Scientiﬁc, 475094) overnight at 4C. The plates
were washed 3 times with DELFIA washing solution
(5 mM Tris-HCl, 0.15 M NaCl, 0.005% Tween 20, 0.01%
NaN3, pH 7.75). Periodate-oxidation was performed for
20 min with 25 mM sodium metaperiodate in 0.1 M
sodium acetate buffer (pH 5.5). The plates were washed
again 3 times with DELFIA washing solution and one
time with PBS/0.05% Tween, and the wells were blocked
for 1h with DELFIA blocking solution (50 mM Tris-
HCl, 0.15 M NaCl, 90 mM CaCl2, 4 mM EDTA, 0.02%
NaN3, and 0.1% BSA) at 22–24C. After discarding the
blocking buffer, the plates were incubated for 1 hour
with 2.5 mM biotin-hydrazide solution in 0.1 M sodium
acetate buffer (pH 5.5) at 22–24C. The plates were
washed again 3 times and then incubated for 1 hour at
22–24C with europium labelled Streptavidin (Perki-
nElmer, 1244–360) 1:1,000 in DELFIA assay buffer (Per-
kinElmer, 1244-111). This was followed by washing the
plates six times with DELFIA washing solution and incu-
bated for 5 min on a shaker with DELFIA enhancement
buffer (PerkinElmer, 1244-114). The ﬂuorescence was
measured using a Wallac 1420 VICTOR2 plate reader
with Europium label protocol (PerkinElmer, Waltham,
MA, USA).
ELISA for MUC5AC detection
Mucin samples were diluted in 0.5 M GuHCl and coated
onto Nunc 96-well polisorp plates (ThermoFisher Scien-
tiﬁc, Roskilde, Denmark) overnight at 4C. The plates
were washed three times with PBS/0.05% Tween with
ELISA washer. The wells were blocked with 1% blocking
reagent for ELISA (Roche, 11112589001) containing
0.05% Tween 20 at 22–24C for 1 hour. After discarding
the blocking buffer, the wells were incubated with anti-
MUC5AC primary antibody (45M1, Sigma-Aldrich,
M5293) diluted 1:8,000 in blocking buffer at 22–24C for
1 hour, followed by washing with washing buffer (PBS/
0.05% Tween 20). The wells were incubated with horse-
radish peroxidase (HRP) conjugated anti-mouse IgG sec-
ondary antibody diluted in blocking buffer at 22–24C
for 1 hour and then washed with washing buffer.
3,3 0,5,5 0-Tetramethylbenzidine (TMB) substrate for
ELISA (Sigma-Aldrich, T0440) was added to the wells
and the color development was monitored. The reaction
was stopped after 20 minutes with 0.5 M H2SO4 and
absorbance was measured at 450 nm.
Proteomic analysis of gastric mucins
Mucin samples (60 mg) were reduced (10mM DTT, 70C
for 1 h) and alkylated (25 mM iodoacetamide (IAA) for
30 min at room temperature, in the dark). The DTT and
IAA were removed using a spin ﬁlter with Amicon Ultra
30kDa cut-off (Merck Millipore, Billerica, MA). The ﬁlter
was pre-washed twice with 200 mL 0.1 M NaOH, followed
by 200 mL H2O. Samples were added and washed thrice
with 200 mL 50 mM (NH4)HCO3 by centrifugation
(5 min at 13,200 rpm). The ﬁlter was then placed up-side
down in the new tube and the proteins were eluted with
2 £ 50 mL (NH4)HCO3. Enzymatic digestion was per-
formed with trypsin (1:100 enzyme to protein, V511A,
Promega, Madison, WI) and 50 mM (NH4)HCO3 and
incubated at 37C for 16 h. C18 ZipTips (Millipore) were
used to enrich the tryptic peptides according to the manu-
facturer’s instructions before proteomic analysis.
Pre- and analytical columns were packed in-house
with 3 mm C18 particles (Dalco Chromtech, Stockholm,
Sweden) with 4 cm x 75 mm I.D. and 15 cm x 50 mm I.D.,
respectively. Solvent A was 0.2% formic acid and solvent
B was 0.2% formic acid in 80% acetonitrile. A linear gradi-
ent was set as follows: 0% B for 5 min, then a gradient up
to 35% B in 70 min and to 80% B in 5 min. A 20 min wash
at 80% was used to ensure that the sample was eluted
from the column and to prevent carryover, and a 25 min
equilibration with 100% completed the gradient. The col-
umn was attached to an Agilent 1100 series HPLC (Agi-
lent Technologies, Santa Clara, CA) and then samples
were analyzed by MS, on an LTQ-Orbitrap XL (Thermo
Scientiﬁc), in positive ion mode for MS and MS2 analysis.
The spray voltage was set to 2 kV, and the ion transfer
tube was set to 200 C. The full scans were acquired in a
Fourier transform MS mass analyzer that covered m/z
range of 400–2000. The MS2 analysis was performed
under data-dependent mode to fragment the top ﬁve pre-
cursors using collision-induced dissociation (CID). For
CID, a normalized collision energy of -35 eV, an isolation
width of m/z 1.0, an activation Q value of 0.250, and a
time of 30 ms were used. Peptide MS/MS spectra were
searched against UniProt and NCBI pig protein databases
using Mascot server (v.2.2.04, Matrix Science Inc., MA,
USA) with in-house build mucin database. The amino
acid sequences of the Sus scrofa MUC5AC and MUC5B
homologs were previously only partial [49]. They were
improved here to cover a larger proportion of the full-
length sequences using various sources of information.
We used 1) available partial protein and mRNA sequen-
ces of Genbank and UniProt, 2) in house sequencing of
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selected portions of the mRNAs and 3) analysis of the
identity of VWD domains using described methods [50].
Our assembly of the pig sequences was also aided by avail-
able sequences of bovine Muc5ac and Muc5b. We also
used a method to identify shorter peptides of the two
mucins where tblastn [49] was used to search Sus scrofa
RNA-Seq data, using bovine mucins as queries. The ﬁnal
sequences of S. scrofa Muc5ac and Muc5b used in this
project are not entirely complete and are not guaranteed
to be correct in every amino acid position, but provided
nevertheless us the ability to efﬁciently discriminate
betweenMUC5AC and MUC5B. For S. scrofaMUC2 and
MUC6, we used protein sequences available in Genbank,
XP_013845199.1 (MUC2) and XP_013845183.1
(MUC6). Both of these entries seem to comprise near
full-length mucin sequences. Only peptides with a mass
deviation lower than 10 ppm were accepted and at least
two peptide sequences with manual inspection were used
for positive protein identiﬁcation.
Release of O-linked mucin oligosaccharides
Sample preparation for LC-MS/MS analysis of glycans:
puriﬁed porcine gastric mucins were dot-blotted onto pol-
yvinylidene ﬂuoride (PVDF) membrane (Immobilin P,
Millipore, Billerica, MA, United States) (approx. 20 mg of
protein per spot, two spots per sample), stained with
Alcian Blue 8GXAlcian Blue 8GX (A5268, Sigma-Aldrich)
for 1hr at RT and destained with methanol. TheO-glycans
were released from PVDF membranes by incubation with
50mL 0.5 MNaBH4 in 50 mMNaOH, 16 hr, at 50C [51].
The reductive b-elimination reaction was quenched by
addition of 1 mL of acetic acid and the samples were
desalted with 35 mL of AG50WX8 cation exchange slurry
(Bio-Rad, Hercules, CA) packed on the top of C18 zip tips
(Millipore). The samples were then dried in SpeedVac and
borate complexes were removed by repeated addition/
evaporation of 50 mL of methanol (ﬁve times). The
released oligosaccharides were dissolved in water.
Selected structures were also analyzed with an LC-
LTQ Orbitrap mass spectrometer (Thermo Electron
Corp.).The LC setup was the same as that described for
LC-ESI-MS/MS. Ions isolated for HCD fragmentation
were acquired with a resolution of 7,500 and subjected to
collision with the collision energy set to 95% with an
activation time of 30 ms. The data were processed using
the Xcalibur software (version 2.2, Thermo Scientiﬁc)
and manually interpreted from their MS/MS spectra.
Helicobacter suis culture conditions
Helicobacter suis strain HS1 and HS5 were cultured in
biphasic Brucella culture plates (BD BBL, 211086)
containing 20% fetal bovine serum (FBS) (HyClone,
SH30071.01), Vitox supplement (Oxoid, SR0090H), Skir-
row Campylobacter selective supplement (Oxoid,
SR0069E), and 5 mg/L amphotericin B. The pH of the
agar was adjusted to 5. One mL sterile brucella broth (pH
5) was added onto the agar surface. The bacteria were cul-
tured under microaerobic conditions at 37C [37].
Binding to puriﬁed mucins and glycoconjugates
using antibody detection
Mucin samples were diluted in 0.5 M GuHCl and glyco-
conjugates of Leb, SLex, LacdiNAc and Lacto-N-tetraose
were diluted in PBS to 4 mg/mL concentrations and
coated on 96-well polysorp plates overnight at 4C. The
plates were washed three times with washing buffer (PBS
with 0.05% Tween 20) and the wells were blocked for
1 hour with 1% Blocking Reagent for ELISA (Roche,
11112589001). After discarding the blocking buffer, bac-
teria were diluted to an OD600 of 0.05 in blocking buffer
(pH 2–7) containing 10mM citric acid and 0.05% Tween
20. For the binding inhibition assay, H. suis was pre-
incubated with 0.5mg/mL of one of the following sugars:
Lacto-N-tetraose (LNT), LS-tetrasaccharide a (LSTa)
(OligoTech, GLY010, GLY081), D-glucose, D-galactose,
N-acetyl-glucosamine, L-fucose, N-acetyl-galactosamine
for 30 min at RT prior to the incubation with mucins.
The pH of the blocking buffer was adjusted with the
addition of HCl that between pH 2 and pH 7 changed
the osmolarity of the buffer with approximately 0.25%.
The 0.25% change was determined to have negligible
effects on the experiments based on that pilot experi-
ments that included addition of 10 mM citrate, which
increased the osmolality with approximately 9% gave
results very similar to those presented herein. The bacte-
rial suspension was added to the plates, which then were
incubated for 2 hours at 37C and 120 rpm. The plates
were washed three times with washing buffer and then
incubated for 1 hour at 22–24C with rabbit anti-H.
pylori serum diluted 1:1,000 in blocking buffer. The
plates were washed three times and incubated for 1 hour
at 22–24C with horseradish peroxidase conjugated anti-
rabbit IgG diluted 1:10,000 in blocking buffer. After fur-
ther washing steps, TMB substrate was added to the wells
and the plates were incubated for 20 min at 22–24C.
The reaction was stopped with an equivalent amount of
0.5 M H2SO4 and absorbance was measured in a micro-
plate reader at 450 nm. The data are presented after sub-
tracting the background signal (the binding of bacteria
to the plastic wells and the binding of antibody to the
mucin). Analyses presented in all ﬁgures except 10A was
performed this way whereas analyses presented in 10A
was performed using biotinylated H. suis (as described
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[45) due to high background signal from the antibody
detection system to some HSA-glycoconjugates.
Binding to puriﬁed mucins and glycoconjugates
using biotinylated bacteria
Biotinylation of bacteria was performed as previously
described [24]. Mucin samples were diluted in 0.5 M
GuHCl to 4 mg/mL and coated on 96-well polysorb
plates over night at 4C. The plates were washed three
times with washing buffer (PBS with 0.05% Tween 20)
and the wells were blocked for 1 hour with 1% Blocking
Reagent for ELISA (Roche, 11112589001). After discard-
ing the blocking buffer, biotinylated bacteria were diluted
to an OD600 of 0.05 in blocking buffer (pH 2–7). The
bacterial suspension was added to the plates, which then
were incubated for 2 hours at 37C and 120 rpm. The
plates were washed 3 times and then incubated for
1 hour at 22–24C with blocking buffer containing 1 mg/
mL of horse radish peroxidase conjugated streptavidin.
After further washing steps, TMB substrate was added
and the plates were incubated for 5 min. The reaction
was stopped with an equivalent amount of 0.5 M H2SO4
and the plates were read in a microplate reader at
450 nm after color stabilization.
Isolation of glycosphingolipids from pig stomach
Total acid and non-acid glycosphingolipids were isolated
from the stomachs (corpus and fundus region) of four
H. suis negative pigs, as previously described [46].
Binding of H. suis and H. pylori to glycosphingolipids
on thin-layer chromatograms
The glycosphingolipids (40 mg/lane) were separated on
aluminum-backed silica gel plates, using chloroform/
methanol/water 60:35:8 (by volume) as solvent system.
Metabolic labeling of H. suis strain HS5 and H. pylori
strain J99 was done by culture in the presence of 35S-
methionine as outlined in [46]. Binding of 35S-labeled
bacteria to glycosphingolipids on thin-layer chromato-
grams was done as described before [46]. Bound bacteria
were detected by autoradiography (12 h).
Endoglycoceramidase digestion
Endoglycoceramidase II from Rhodococcus spp. (Takara
Bio Europe S.A., Gennevilliers, France) was used for
hydrolysis of the non-acid glycosphingolipids. The glyco-
sphingolipids (50 mg) were resuspended in 100 mL
0.05 M sodium acetate buffer, pH 5.0, containing 120 mg
sodium cholate, and sonicated brieﬂy. Thereafter, 1 mU
of enzyme was added, and the mixture was incubated at
37 C for 48 h. The reaction was stopped by addition of
chloroform/methanol/water to the ﬁnal proportions
8:4:3 (by volume). The oligosaccharide-containing upper
phase thus obtained was separated from detergent on a
Sep-Pak QMA cartridge (Waters). The eluent containing
the oligosaccharides was dried under nitrogen.
LC-ESI MS-analysis of mucin- and glycosphingolipid-
derived oligosaccharides
Oligosaccharides were resuspended in 50 mL of water
and analyzed by LC-ESI/MS as described [35]. The oligo-
saccharides were separated on a column (100 £
0.250 mm) packed in-house with 5 mm porous graphite
particles (Hypercarb, Thermo-Hypersil, Runcorn, UK).
An autosampler, HTC-PAL (CTC Analytics AG, Zwin-
gen, Switzerland) equipped with a cheminert valve
(0.25 mm bore) and a 2 mL loop, was used for sample
injection. An Agilent 1100 binary pump (Agilent tech-
nologies, Palo Alto, CA) delivered a ﬂow of 250 ml/min,
which was split down in an 1/16” microvolume-T
(0.15 mm bore) (Vici AG International, Schenkon, Swit-
zerland) by a 50 cm x 50 mm i.d. fused silica capillary
before the injector of the autosampler, allowing approxi-
mately 2–3 ml/min through the column. The oligosac-
charides (3 mL) were injected on to the column and
eluted with an acetonitrile gradient (A: 10 mM ammo-
nium bicarbonate; B: 10 mM ammonium bicarbonate in
80% acetonitrile). The gradient (0-50% B) was eluted for
46 min, followed by a wash step with 100% B, and equili-
bration of the column for 24 min. A 30 cm x 50 mm i.d.
fused silica capillary was used as transfer line to the ion
source.
The saccharides were analyzed in negative ion mode
on an LTQ linear ion trap mass spectrometer (Thermo
Electron, San Jose, CA). The IonMax standard ESI
source on the LTQ mass spectrometer was equipped
with a stainless steel needle kept at¡3.2 kV. Compressed
air was used as nebulizer gas. The heated capillary was
kept at 310 C, and the capillary voltage was ¡50 kV.
Full-scan (m/z 380–2,000, 2 microscans, maximum
100 ms, target value of 30,000) was performed, followed
by data dependent MS2 scans of the three most abundant
ions in each scan (2 microscans, maximum 100 ms, tar-
get value of 10,000). The threshold for MS2 was set to
300 counts. Normalized collision energy was 35%, and
an isolation window of 3 u, an activation q = 0.25, and
an activation time of 30 ms, was used. Data acquisition
and processing were conducted with Xcalibur software
(Version 2.0.7 or 2.2). Selected structures were also ana-
lyzed with an LC-LTQ Orbitrap mass spectrometer
(Thermo Electron Corp.).The LC setup was the same as
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that described for LC-ESI-MS/MS. Ions isolated for HCD
fragmentation were acquired with a resolution of 7,500
and subjected to collision with the collision energy set to
95% with an activation time of 30 ms.
Manual assignment of glycan sequences was done on
the basis of knowledge of mammalian biosynthetic path-
ways, with the assistance of the Glycoworkbench tool
(Version 2.1), and by comparison of retention times and
MS2 spectra of oligosaccharides from reference glyco-
sphingolipids [35].
Abreviations
BabA Blood group antigen binding adhesin
CID Collision-induced dissociation
DTT Dithiothreitol
EIC Extracted ion chromatogram
ELISA Enzyme-linked immunosorbent assay
FBS Fetal bovine serum
GI Gland insoluble
GS Gland soluble
GuHCl Guanidinium chloride
HCD Higher-energy collisional dissociation
HpaA Helicobacter pylori adhesin A
H. pylori Helicobacter pylori
H. suis Helicobacter suis
HRP Horseradish peroxidase
IAA Iodoacetamide
Le Lewis
LNnT Lacto-N-neotetraose
LNT Lacto-N-tetraose
LSTa LS-tetrasaccharide a
MALT Mucosa-associated lymphoid tissue
OD Optical density
OMPs Outer membrane proteins
PMSF Phenylmethyl sulphonyl ﬂuorid
PVDF Polyvinylidene ﬂuoride
SabA Sialic acid binding adhesin
SI Surface insoluble
SLea Sialyl-Lea
SLex Sialyl-Lex
SS Surface soluble
TMB 3,3 0,5,5 0-Tetramethylbenzidine
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